NY State Senate Bill 2017-S6759

Archive: Last Bill Status - In Senate Committee Health Committee

Introduced
- In Committee Assembly
- In Committee Senate
- On Floor Calendar Assembly
- On Floor Calendar Senate
- Passed Assembly
- Passed Senate
Delivered to Governor
Signed By Governor

Please enter your contact information

First Name

Last Name

Email Address

A valid email address is required.

Home address is used to determine the senate district in which you reside. Your support or opposition to this bill is then shared immediately with the senator who represents you.

Optional services from the NY State Senate:

Create an account. An account allows you to officially support or oppose key legislation, sign petitions with a single click, and follow issues, committees, and bills that matter to you. When you create an account, you agree to this platform's terms of participation.

Include a custom message for your Senator? (Optional)

Enter a message to your senator. Many New Yorkers use this to share the reasoning behind their support or opposition to the bill. Others might share a personal anecdote about how the bill would affect them or people they care about.

Actions

View Actions

Date of Action	Assembly Actions - Lowercase Senate Actions - UPPERCASE
Jan 03, 2018	referred to health returned to senate died in assembly
Jun 20, 2017	referred to health delivered to assembly passed senate ordered to third reading cal.2106
Jun 16, 2017	referred to rules

Votes

- Jun 20, 2017 - Floor Vote
  S6759
  
  Aye
  
  63
  
  Nay
  
  0
  
  Absent
  
  0
  
  Excused
  
  0
  
  Abstained
  
  0
  - - Floor Vote: Jun 20, 2017
      
      aye (63)
      
      Addabbo Jr.
      
      Akshar
      
      Alcantara
      
      Amedore
      
      Avella
      
      Bailey
      
      Benjamin
      
      Bonacic
      
      Boyle
      
      Breslin
      
      Brooks
      
      Carlucci
      
      Comrie
      
      Croci
      
      DeFrancisco
      
      Diaz
      
      Dilan
      
      Felder
      
      Flanagan
      
      Funke
      
      Gallivan
      
      Gianaris
      
      Golden
      
      Griffo
      
      Hamilton
      
      Hannon
      
      Helming
      
      Hoylman-Sigal
      
      Jacobs
      
      Kaminsky
      
      Kennedy
      
      Klein
      
      Krueger
      
      LaValle
      
      Lanza
      
      Larkin
      
      Latimer
      
      Little
      
      Marcellino
      
      Marchione
      
      Montgomery
      
      Murphy
      
      O'Mara
      
      Ortt
      
      Parker
      
      Peralta
      
      Persaud
      
      Phillips
      
      Ranzenhofer
      
      Ritchie
      
      Rivera
      
      Robach
      
      Sanders Jr.
      
      Savino
      
      Serino
      
      Serrano
      
      Seward
      
      Squadron
      
      Stavisky
      
      Stewart-Cousins
      
      Tedisco
      
      Valesky
      
      Young
  Jun 20, 2017 - Rules Committee Vote
  S6759
  
  Aye
  
  24
  
  Nay
  
  0
  
  Aye with Reservations
  
  1
  
  Absent
  
  0
  
  Excused
  
  0
  
  Abstained
  
  0
  - - Rules Committee Vote: Jun 20, 2017
      
      aye (24)
      
      Bonacic
      
      Breslin
      
      Carlucci
      
      DeFrancisco
      
      Dilan
      
      Flanagan
      
      Griffo
      
      Hannon
      
      Kennedy
      
      Krueger
      
      LaValle
      
      Lanza
      
      Larkin
      
      Little
      
      Marcellino
      
      Montgomery
      
      Parker
      
      Ranzenhofer
      
      Robach
      
      Savino
      
      Seward
      
      Squadron
      
      Stewart-Cousins
      
      Valesky
      
      aye wr (1)
      
      Gianaris

2017-S6759 (ACTIVE) - Details

Current Committee:: Senate Health
Law Section:: Public Health Law
Laws Affected:: Amd §3306, Pub Health L

2017-S6759 (ACTIVE) - Summary

Provides for the express addition and addition by reference of numerous controlled substances to the state schedules of controlled substances.

2017-S6759 (ACTIVE) - Sponsor Memo

                                 BILL NUMBER:  S6759

 TITLE OF BILL :  An act to amend the public health law, in relation
to adding substances to the schedules of controlled substances

 PURPOSE :

This bill would update the State controlled substances schedules,
promoting consistency with the federal schedules and promoting health
and safety.

 SUMMARY OF PROVISIONS :

Section 1 of the bill would add a synthetic opioid analgesic; often
known as AH-7921, and one fentanyl analog, Acetytl Fentanyl, to
Schedule I (b) of Public Health Law (PHL) § 3306.

Section 2 of the bill would amend PHL § 3306, Schedule I (d) to
correct the spelling of ibogane to ibogaine.

Section 3 of the bill would add a number of substances to PHL § 3306,
Schedule I (d).

Section 4 of the bill would amend PHL § 3306, Schedule II (h) to add
methasterone and prostanozol.

Section 5 of the bill would amend PHL § 3306, Schedule III (c) to add
perampanel.

Section 6 of the bill would amend PHL § 3306, Schedule IV (c) to add
alfaxalone and suvorexant.

Section 7 of the bill would amend PHL § 3306, Schedule IV (f) to
clarify that the inclusion of salts and isomers applies whenever such
salts or isomers are possible within the specific chemical designation
of a substance. The section also would add lorcaserin and eluxadoline
to Schedule IV (f).

Section 8 of the bill would amend PHL § 3306, Schedule V (d) to add
brivaracetam. Section 9 would set forth the effective date.

 JUSTIFICATION :

This bill would update the New York State controlled substances
schedules to conform to the current federal schedules of controlled
substances. Individuals often exploit the fact that certain drugs
classified as controlled substances under federal law are not
similarly classified as controlled substances under New York law, and
thus are more easily diverted. Consistency between the State and
federal schedules is therefore important to address the prevalence of
abuse and misuse of controlled substances.

The bill would also add other known dangerous substances to the State
schedule of controlled substances, including a synthetic opioid
analgesic, often is known as AH-7921, which can cause a psychoactive
reaction and has led to a number of deaths within the United States
and other counties. Additionally, the bill would clarify that the
inclusion of salts and isomers applies whenever such salts or isomers
are possible within the specific chemical designation of a substance.

 LEGISLATIVE HISTORY :

New bill.

 FISCAL IMPLICATIONS :

None.

 EFFECTIVE DATE :
90 days, succeeding enactment.

2017-S6759 (ACTIVE) - Bill Text download pdf

                            
 
                     S T A T E   O F   N E W   Y O R K
 ________________________________________________________________________
 
                                   6759
 
                        2017-2018 Regular Sessions
 
                             I N  S E N A T E
 
                               June 16, 2017
                                ___________
 
 Introduced  by  Sen.  HANNON -- read twice and ordered printed, and when
   printed to be committed to the Committee on Rules
 
 AN ACT to amend the public health law, in relation to adding  substances
   to the schedules of controlled substances
 
   THE  PEOPLE OF THE STATE OF NEW YORK, REPRESENTED IN SENATE AND ASSEM-
 BLY, DO ENACT AS FOLLOWS:
 
   Section 1. Subdivision (b) of schedule I of section 3306 of the public
 health law is amended by adding two new paragraphs 56 and 57 to read  as
 follows:
   (56) 3,4-DICHLORO-N-{(1-DIMETHYLAMINO)CYCLOHEXYLMETHYL}BENZAMIDE. SOME
 TRADE OR OTHER NAMES: AH-7921.
   (57) N-(1-PHENETHYLPIPERIDIN-4-YL)-N-PHENLYACETAMIDE   (ACETYL  FENTA-
 NYL).
   § 2. Paragraph 11 of subdivision (d) of schedule I of section 3306  of
 the  public  health law, as added by chapter 664 of the laws of 1985, is
 amended to read as follows:
   (11) [Ibogane] IBOGAINE Some trade and other names: 7-ethyl-6, 6&,  7,
 8,  9, 10, 12, 13-octahydro-2-methoxy-6, 9-methano-5h-pyrido {1',2':1,2}
 azepino {5,4-b} indole: tabernanthe iboga.
   § 3. Subdivision (d) of schedule I  of  section  3306  of  the  public
 health  law  is amended by adding thirty-four new paragraphs 36, 37, 38,
 39, 40, 41, 42, 43, 44, 45, 46, 47, 48, 49, 50, 51, 52, 53, 54, 55,  56,
 57,  58,  59,  60,  61,  62,  63,  64,  65, 66, 67, 68 and 69 to read as
 follows:
   (36) 5-METHOXY-N,N-DIMETHYLTRYPTAMINE.
   (37) ALPHA-METHYLTRYPTAMINE. SOME TRADE OR OTHER NAMES: AMT.
   (38) 5-METHOXY-N,N-DIISOPROPYLTRYPTAMINE. SOME TRADE OR  OTHER  NAMES:
 5-MEO-DIPT.
   (39) 5-(1,1-DIMETHYLHEPTYL)-2-{(1R,3S)-3-HYDROXYCYCLOHEXYL}-PHENOL.
 SOME TRADE OR OTHER NAMES: CP-47,497.
 
  EXPLANATION--Matter in ITALICS (underscored) is new; matter in brackets
                       [ ] is old law to be omitted.
                                                            LBD13230-01-7

 S. 6759                             2
 
   (40)     5-(1,1-DIMETHYLOCTYL)-2-{(1R,3S)-3-HYDROXYCYCLOHEXYL}-PHENOL.
 SOME TRADE OR OTHER NAMES: CANNABICYCLOHEXANOL OR CP-47,497 C8-HOMOLOG.
   (41)   1-BUTYL-3-(1-NAPHTHOYL)INDOLE.   SOME  TRADE  OR  OTHER  NAMES:
 JWH-073.
   (42)  1-HEXYL-3-(1-NAPHTHOYL)INDOLE.  SOME  TRADE  OR   OTHER   NAMES:
 JWH-019.
   (43)  1-{2-(4-MORPHOLINYL)ETHYL}-3-(1-NAPHTHOYL)INDOLE.  SOME TRADE OR
 OTHER NAMES: JWH-200.
   (44) 1-PENTYL-3-(2-METHOXYPHENYLACETYL)INDOLE.  SOME  TRADE  OR  OTHER
 NAMES: JWH-250.
   (45)  1-PENTYL-3-{1-(4-METHOXYNAPHTHOYL)}INDOLE.  SOME  TRADE OR OTHER
 NAMES: JWH-081.
   (46)  1-PENTYL-3-(4-METHYL-1-NAPHTHOYL)INDOLE.  SOME  TRADE  OR  OTHER
 NAMES:  JWH-122.
   (47)  1-PENTYL-3-(4-CHLORO-1-NAPHTHOYL)INDOLE.  SOME  TRADE  OR  OTHER
 NAMES:  JWH-398.
   (48) 1-(5-FLUOROPENTYL)-3-(1-NAPHTHOYL)INDOLE.  SOME  TRADE  OR  OTHER
 NAMES: AM2201.
   (49)  1-(5-FLUOROPENTYL)-3-(2-IODOBENZOYL)INDOLE.  SOME TRADE OR OTHER
 NAMES: AM694.
   (50)  1-PENTYL-3-{(4-METHOXY)-BENZOYL}INDOLE.  SOME  TRADE  OR   OTHER
 NAMES: SR-19 AND RCS-4.
   (51)  1-CYCLOHEXYLETHYL-3-(2-METHOXYPHENYLACETYL)INDOLE. SOME TRADE OR
 OTHER NAMES: SR-18 AND RCS-8.
   (52)  1-PENTYL-3-(2-CHLOROPHENYLACETYL)INDOLE.  SOME  TRADE  OR  OTHER
 NAMES:  JWH-203.
   (53)  (1-PENTYL-1H-INDOL-3-YL)(2,2,3,3-TETRAMETHYLCYCLOPROPYL)  METHA-
 NONE. SOME TRADE OR OTHER NAMES: UR-144.
   (54)
 {1-(5-FLUORO-PENTYL)-1H-INDOL-3-YL}(2,2,3,3-TETRAMETHYLCYCLOPROPYL)
 METHANONE. SOME TRADE OR OTHER NAMES: 5-FLUORO-UR-144,XLR11.
   (55) N-(1-ADAMANTYL)-1-PENTLY-1H-INDAZOLE-3-CARBOXAMIDE. SOME TRADE OR
 OTHER NAMES: APINACA, AKB 48.
   (56) QUINOLIN-8-YL  1-PENTYL-1H-INDOLE-3-CARBOXYLATE.  SOME  TRADE  OR
 OTHER NAMES: PB-22 AND QUPIC.
   (57)  QUINOLIN-8-YL  1-(5-FLUOROPENTYL)-1H-INDOLE-3-CARBOXYLATE.  SOME
 TRADE OR OTHER NAMES: 5-FLUORO-PB-22 AND 5F-PB-22.
   (58)  N-(1-AMINO-3-METHYL-1-OXOBUTAN-2-YL)-1-(4-FLUOROBENZYL)-1H-INDA-
 ZOLE-3-CARBOXAMIDE. SOME TRADE OR OTHER NAMES: AB-FUBINACA.
   (59)  N-(1-AMINO-3,3-DIMETHYL-1-OXOBUTAN-2-YL)-1-PENTYL-1H-INDAZOLE-3-
 CARBOXAMIDE. SOME TRADE OR OTHER NAMES: ADB-PINACA.
   (60) 4-METHYL-N-ETHYLCATHINONE. SOME TRADE OR OTHER NAMES: 4-MEC.
   (61)  4-METHYL-ALPHA-PYRROLIDINOPROPIOPHENONE.  SOME  TRADE  OR  OTHER
 NAMES: 4-MEPPP.
   (62) ALPHA-PYRROLIDINOPENTIOPHENONE. SOME TRADE OR OTHER NAMES: A-PVP.
   (63)  1-(1,3-BENZODIOXOL-5-YL)-2-(METHYLAMINO)BUTAN-1-ONE.  SOME TRADE
 OR OTHER NAMES: BUTYLONE AND BK-MBDB.
   (64) 2-(METHYLAMINO)-1-PHENYLPENTAN-1-ONE. SOME TRADE OR OTHER  NAMES:
 PENTEDRONE.
   (65) 1-(1,3-BENZODIOXOL-5-YL)-2-(METHYLAMINO)PENTAN-1- ONE. SOME TRADE
 OR OTHER NAMES: PENTYLONE AND BK-MBDP.
   (66)  4-FLUORO-N-METHYLCATHINONE. SOME TRADE OR OTHER NAMES: 4-FMC AND
 FLEPHEDRONE.
   (67) 3-FLUORO-N-METHYLCATHINONE. SOME TRADE OR OTHER NAMES: 3-FMC.
   (68) 1-(NAPHTHALEN-2-YL)-2-(PYRROLIDIN-1-YL)PENTAN-1-ONE.  SOME  TRADE
 OR OTHER NAMES: NAPHYRONE.

 S. 6759                             3
 
   (69) ALPHA-PYRROLIDINOBUTIOPHENONE. SOME TRADE OR OTHER NAMES: A-PBP.
   §  4.  Subdivision  (h)  of  schedule II of section 3306 of the public
 health law is amended by adding two new paragraphs 64 and 65 to read  as
 follows:
   (64) METHASTERONE (2{ALPHA}17{ALPHA}-DIMETHYL-5{ALPHA}-ANDROSTAN-
 17{BETA}-OL-3-ONE).
   (65) PROSTANOZOL (17{BETA}-HYDROXY-5{ALPHA}-ANDROSTANO{3,2-C}PYRAZOLE).
   §  5.  Subdivision  (c)  of schedule III of section 3306 of the public
 health law is amended by adding a new paragraph 15 to read as follows:
   (15) PERAMPANEL.
   § 6. Subdivision (c) of schedule IV of  section  3306  of  the  public
 health  law is amended by adding two new paragraphs 54 and 55 to read as
 follows:
   (54) ALFAXALONE.
   (55) SUVOREXANT.
   § 7. Subdivision (f) of schedule IV of  section  3306  of  the  public
 health  law, as added by chapter 664 of the laws of 1985, paragraph 2 as
 added by chapter 457 of the laws of 2006 and paragraph  3  as  added  by
 section  14  of part C of chapter 447 of the laws of 2012, is amended to
 read as follows:
   (f) Other substances. Unless specifically excepted or unless listed in
 another schedule, any material, compound, mixture or  preparation  which
 contains  any quantity of the following substances, including its salts,
 ISOMERS, AND SALTS, OF SUCH ISOMERS,  WHENEVER  THE  EXISTENCE  OF  SUCH
 SALTS, ISOMERS, AND SALTS OF ISOMERS IS POSSIBLE:
   (1) Pentazocine.
   (2) Butorphanol (including its optical isomers).
   (3) Tramadol in any quantities.
   (4) LORCASERIN.
   (5) ELUXADOLINE.
   §  8.  Subdivision  (d)  of  schedule  V of section 3306 of the public
 health law is amended by adding a new paragraph 4 to read as follows:
   (4) BRIVARACETAM.
   § 9. This act shall take effect on the ninetieth day  after  it  shall
 have become a law.

Comments

Open Legislation is a forum for New York State legislation. All comments are subject to review and community moderation is encouraged.

Comments deemed off-topic, commercial, campaign-related, self-promotional; or that contain profanity, hate or toxic speech; or that link to sites outside of the nysenate.gov domain are not permitted, and will not be published. Attempts to intimidate and silence contributors or deliberately deceive the public, including excessive or extraneous posting/posts, or coordinated activity, are prohibited and may result in the temporary or permanent banning of the user. Comment moderation is generally performed Monday through Friday. By contributing or voting you agree to the Terms of Participation and verify you are over 13.

Create an account. An account allows you to sign petitions with a single click, officially support or oppose key legislation, and follow issues, committees, and bills that matter to you. When you create an account, you agree to this platform's terms of participation.

Find your Senator and share your views on important issues.

Do you support this bill?

Senate Bill S6759

Sponsored By

Archive: Last Bill Status - In Senate Committee Health Committee

Actions

Votes

Jun 20, 2017 - Floor Vote

Floor Vote: Jun 20, 2017

Jun 20, 2017 - Rules Committee Vote

Rules Committee Vote: Jun 20, 2017

2017-S6759 (ACTIVE) - Details

2017-S6759 (ACTIVE) - Summary

2017-S6759 (ACTIVE) - Sponsor Memo

2017-S6759 (ACTIVE) - Bill Text download pdf

Comments

Do you support this bill?

Get Status Alerts for 2017-S6759

Senate Bill S6759

Share this bill

Sponsored By

Kemp Hannon

Archive: Last Bill Status - In Senate Committee Health Committee

Actions

Votes

2017-S6759 (ACTIVE) - Details

2017-S6759 (ACTIVE) - Summary

2017-S6759 (ACTIVE) - Sponsor Memo

2017-S6759 (ACTIVE) - Bill Text download pdf

Comments